EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Developing the World‐Wide FINGERS biorepository for dementia risk reduction trials

Anna Matton, Chinedu Udeh‐Momoh, Makrina Daniilidou, Erika Bereczki, Vilma Alanko, Paola Padilla, Laura D. Baker, Kitti Ban, Miguel G. Borda, Paulo Caramelli, Pablo Martinez‐Lage Alvarez, Marta del Campo, Carlo Ferrarese, Tobias Hartmann, Hamidul Huque, Thomas K. Karikari, Derya Kaya, Rejko Kruger, Yi‐Chun Kuan, Mitchell K. P. Lai, Karen Mather, Emily Meyers, Njideka Okubadejo, Stanley Onyango, Norfadilah Rajab, Maria Vania Rocha da Silva Nunes, Anna Rosenberg, Gessica Sala, Rosa Maria Salinas Contreras, Shahin Sayed, Margaret Scales, Seong Hye Choi, Hamid Sohrabi, Hilkka Soininen, Taiki Sugimoto, Ezequiel Surace, Yongxiang Wang, Henrik Zetterberg, Marissa Zwan, Ari Solomon

Alzheimer's & Dementia · 2026-11 · 22 (11)

DOI: 10.1002/alz.71949 ↗
AbstractBibliografische Angaben

Abstract

Abstract INTRODUCTION Dementia prevention research increasingly uses multimodal interventions. Harmonized biomarker practices are essential to enable comparable cross‐population analysis with initiatives such as the World‐Wide FINGERS (WW‐FINGERS) network contributing to this effort. METHODS To advance globally representative biomarker research in dementia prevention trials, we conducted a cross‐sectional, network‐wide survey of WW‐FINGERS teams assessing biospecimen collection, processing and storage, biomarker measurements, and readiness for harmonized procedures. RESULTS Most studies (30/39) had or were developing biorepositories; four planned collection and five had none. Practices were broadly aligned, but remaining variability highlights priority targets for harmonization. Clinical biomarkers (lipids, glucose, liver/kidney function) were obtained even in lower‐resourced settings. Many studies measured Alzheimer's disease and related dementias (ADRD) biomarkers (blood‐based amyloid/tau and neurodegeneration; cerebrospinal fluid where feasible) and increasingly used multi‐omics platforms. Evidence‐based preanalytical guidance were provided. CONCLUSION The WW‐FINGERS biorepository provides a world‐first platform for harmonized biomarker discovery across diverse populations in dementia prevention, helping to reduce inequities in research participation, accelerating globally representative strategies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →